Summary
GlobalData, the industry analysis specialist's new report on the pharmaceutical and healthcare sector, "Atopic Dermatitis-Drug Pipeline Analysis and Market Forecasts to 2016" is an essential source of information and analysis on the global atopic dermatitis market. The report identifies the key trends shaping and driving the global atopic dermatitis market, a key segment within the pharma industry. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global atopic dermatitis sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData's team of industry experts.

Scope
The scope of the report includes:
-Annualized global Atopic dermatitis therapeutics market revenues data from 2001 to 2009, forecast forward for 7 years to 2016.
-Geographies covered in this report include the US, the UK, Italy, Spain, Germany, France, and Japan.
-Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends. Key classes of mechanism of action include Anti-inflammatory molecules, Immunomodulators which included immunosuppresants,  NF-kB Inhibitors and blockers, Calcenurin Inhibitors, Inteleukin inhibitors, keratinocyte inhibitors, anti-neoplastics, vaccines, histmaine H1-antagonists, TSLP interaction inhibitors, phosphodiesterase 4 (PDE4) inhibitor, chymase inhibitors, selective glucocorticoid receptor agonist, selective cannabinoid 2 receptor agonist, RAFT Modulator, cytokine modulator and alpha-1 proteinase inhibitors.
-Analysis of the current and future market competition in the global Atopic dermatitis therapeutics market. Key market players covered are Provectus Pharmaceuticals, Barrier Therapeutics and JADO Tehcnologies GmbH.
-Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
-Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with Atopic dermatitis.

Reasons to buy
The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:
-Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.
-Develop business strategies by understanding the trends shaping and driving the global atopic dermatitis market.
-Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global atopic dermatitis market in future.
-Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
-Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
-Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
-What's the next big thing in the global atopic dermatitis market landscape? -Identify, understand and capitalize.

Table of Contents
1 Table of contents
1 Table of contents 3
1.1 List of Tables 5
1.2 List of Figures 5
2 Atopic Dermatitis Therapeutics Market: Market Characterization 6
2.1 Overview 6
2.2 Atopic Dermatitis Therapeutics Market Size 6
2.3 Atopic Dermatitis Therapeutics Market Forecast and CAGR 7
2.4 Drivers and Barriers for the Atopic Dermatitis Therapeutics Market 8
2.4.1 Drivers for the Atopic Dermatitis Therapeutics Market 8
2.4.2 Barriers for the Atopic Dermatitis Therapeutics Market 9
2.5 Opportunity and Unmet Need 10
2.6 Key Takeaway 11
3 Atopic Dermatitis Therapeutics Market: Competitive Assessment 12
3.1 Overview 12
3.2 Strategic Competitor Assessment 12
3.3 Product Profile for the Major Marketed Products in the Atopic Dermatitis Therapeutics Market 13
3.3.1 Protopic (Tacrolimus) 13
3.3.2 Elidel (Pimecrolimus) 14
3.3.3 MimyX 16
3.3.4 Atopiclair 16
3.3.5 Topical Corticosteroids 17
3.4 Key Takeaway 19
4 Atopic Dermatitis Therapeutics Market: Pipeline Assessment 20
4.1 Overview 20
4.2 Strategic Pipeline Assessment 20
4.2.1 Technology Trends Analytical Framework 20
4.3 Atopic Dermatitis Therapeutics-Promising Drugs under Clinical Development 21
4.4 Molecule Profile for Promising Drugs under Clinical Development 21
4.4.1 PH-10 21
4.4.2 Hivenyl 22
4.4.3 TF002 23
4.5 Atopic Dermatitis Therapeutics Market-Clinical Pipeline by Mechanism of Action 24
4.6 Atopic Dermatitis Therapeutics Pipeline-Pipeline by Clinical Phases of Development 25
4.6.1 Atopic Dermatitis Therapeutics-Phase III Clinical Pipeline 25
4.6.2 Atopic Dermatitis Therapeutics-Phase II Clinical Pipeline 26
4.6.3 Atopic Dermatitis Therapeutics-Phase I Clinical Pipeline 27
4.6.4 Atopic Dermatitis Therapeutics-Pre-clinical Pipeline 27
4.6.5 Atopic Dermatitis Therapeutics-Discovery Pipeline 27
4.7 Key Takeaway 28
5 Atopic Dermatitis Market: Implications for Future Market Competition 29
6 Atopic Dermatitis Therapeutics Market: Future Players in the Atopic Dermatits Therapeutics Market 30
6.1 Introduction 30
6.2 Provectus Pharmaceuticals 30
6.2.1 Overview 30
6.2.2 Financial Performance 30
6.2.3 Major Products and Services 31
6.2.4 Dermatology Disease Portfolio 31
6.2.5 Atopic Dermatitis Pipeline Portfolio 31
6.3 Barrier Therapeutics 32
6.3.1 Company Overview 32
6.3.2 Business Description 32
6.3.3 Dermatology Disease Portfolio 32
6.3.4 Atopic Dermatitis Pipeline Portfolio 32
7 Atopic Dermatitis Market: Appendix 34
7.1 Definitions 34
7.2 Acronyms 34
7.3 Research Methodology 35
7.3.1 Coverage 35
7.3.2 Secondary Research 35
7.3.3 Forecasting 36
7.3.4 Primary Research 38
7.3.5 Expert Panel Validation 39
7.4 Contact Us 39
7.5 Disclaimer 39
7.6 Sources 40

List of Tables
1.1 List of Tables
Table 1: Atopic Dermatitis Therapeutics Market, Global, Revenues ($m), 2001-2009 7
Table 2: Atopic Dermatitis Therapeutics Market, Global, Revenues ($m), 2009-2016 8
Table 3: Atopic Dermatitis Therapeutics Market, Global, Key Examples of Clinical Studies Conducted on Herbal Products, 2010 9
Table 4: Atopic Dermatitis Therapeutics Market, Global, Comparative Study on the Efficacy of Protopic in Phase III Clinical Trials, 2003 14
Table 5: Atopic Dermatitis Therapeutics Market, Global , Comparative Study on the Efficacy of Elidel in Clinical Trials, 1998-2002 15
Table 6: Atopic Dermatitis Therapeutics Market, Global, Key Topical Corticosteroid Therapeutics and Brands, 2010 18
Table 7: Major Marketed Products Comparison in the Atopic Dermatitis Therapeutics Market, 2010 19
Table 8: Atopic Dermatitis Therapeutics-Most Promising Drugs Under Clinical Development, November 2009 21
Table 9: Atopic Dermatitis Therapeutics-Phase III Clinical Pipeline, 2010 25
Table 10: Atopic Dermatitis Therapeutics-Phase II Clinical Pipeline, 2010 26
Table 11: Atopic Dermatitis Therapeutics-Phase I Clinical Pipeline, 2010 27
Table 12: Atopic Dermatitis Therapeutics-Pre-Clinical Pipeline, 2010 27
Table 13: Atopic Dermatitis Therapeutics-Discovery Pipeline, 2010 27
Table 14: Provectus Pharmaceuticals-Dermatology Marketed Products, 2010 31
Table 15: Provectus Pharmaceuticals-Atopic Dermatitis Pipeline Products, 2010 31
Table 16: Barrier Therapeutics (Stiefel Laboratories)-Dermatology Marketed Products, 2010 32
Table 17: Barrier Therapeutics (Stiefel Laboratories)-Atopic Dermatitis Pipeline Products, 2010 32

List of Figures
1.2 List of Figures
Figure 1: Atopic Dermatitis Therapeutics Market, Global, Revenues ($m), 2001-2009 7
Figure 2: Atopic Dermatitis Therapeutics Market, Global, Revenues ($m), 2009-2016 8
Figure 3: Opportunity and Unmet Need in the Atopic Dermatitis Therapeutics Market, 2010 10
Figure 4: Strategic Competitor Assessment of the Major Marketed Products in Atopic Dermatitis Therapeutics, 2010 12
Figure 5: Technology Trends Analytic Framework of the Atopic Dermatitis Therapeutics Pipeline, 2010 20
Figure 6: Technology Trends Analytic Framework  of the Atopic Dermatitis Therapeutics Pipeline-Description, 2010 21
Figure 7: Atopic Dermatitis Therapeutics Market-Clinical Pipeline by Mechanism of Action, 2010 24
Figure 8: Atopic Dermatitis Therapeutics Pipeline by Phase of Clinical Development, 2010 25
Figure 9: Implications for Future Market Competition in the Atopic Dermatitis Therapeutics Market Market, 2010 29
Figure 10: Atopic Dermatitis Therapeutics Market-Clinical Pipeline by Company, 2010 30
Figure 11: GlobalData Methodology 35
Figure 12: GlobalData  Market Forecasting Model 38